Itamar Medical Ltd (ITMR) Stock

DelistedNasdaq: ITMRItamar Medical Ltd., a medical technology company, develops and commercializes non-invasive medical devices and solutions for the treatment of respiratory sleep disorders.

30.87
Final close · Dec 15, 2021

ITMR is no longer traded. Itamar Medical was delisted from the Nasdaq in December 2021.

Prices on this page are historical; the last trade was December 15, 2021 at $30.87.

Itamar Medical stock price history

Split-adjusted closes, 2019–2021

ITMR final trading statistics

Final close
$30.87
Final trading day
Dec 15, 2021
Market cap at delisting
$506.91M
Shares outstanding
16.42M
Final 52-week range
$16.36 – $30.91
Avg. volume (final 3 mo.)
159,161
All-time high (split-adj.)
$30.87 · Dec 2021
All-time low (split-adj.)
$7.95 · Mar 2020
Return since IPO
+157.3%
Beta
0.54
Book value / share
$4.50
Price / book
6.86
Final 52 wk
16.3630.91

Itamar Medical earnings per share

Earnings per share

Itamar Medical revenue & net income

RevenueNet income

Itamar Medical annual financials

Itamar Medical Ltd revenue, net income and EPS by fiscal year
Fiscal yearRevenueNet incomeEPS
FY2020$41.03M-$10.9M-$0.79
FY2019$31.26M-$5.3M-$0.39
FY2018$24.19M-$1.7M—
FY2017$20.70M-$5.3M—
FY2016$18.44M-$14.4M—

Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.

About Itamar Medical Ltd

Itamar Medical Ltd., a medical technology company, develops and commercializes non-invasive medical devices and solutions for the treatment of respiratory sleep disorders. The company offers medical devices based on Peripheral Arterial Tone (PAT) signal, which measures changes in the patient's peripheral arterial pulse volumes and various parameters of arterial activities. It provides WatchPAT device, which enable to conduct home sleep apnea tests for the treatment of sleep apnea, such as obstructive sleep apnea; EndoPAT device that diagnoses endothelial dysfunction; and Loop device, a wrist device for measuring and recording physiological parameters, such as SpO2, respiration rate, and heart rate. The company operates in the United States, Canada, Europe, Israel, Japan, rest of the Asia Pacific, and internationally. The company was formerly known as Itamar Medical (CM) 1997 Ltd. and changed its name to Itamar Medical Ltd. in July 2000. Itamar Medical Ltd. was incorporated in 1997 and is headquartered in Caesarea, Israel. As of December 16, 2021, Itamar Medical Ltd. operates as a subsidiary of ZOLL Medical Corporation.

Itamar Medical stock FAQ

What happened to Itamar Medical stock?

Itamar Medical stock was delisted from the Nasdaq. Its final close was $30.87 on December 15, 2021.

Is ITMR stock still trading?

No. ITMR was delisted from the Nasdaq in December 2021 and no longer trades on a U.S. exchange.

What was the last price of ITMR stock?

ITMR closed at $30.87 on its final trading day, December 15, 2021, for a market value of about $506.91M.

What were Itamar Medical's revenue and earnings in its last full fiscal year?

Itamar Medical reported revenue of $41.03M and net income of -$10.9M in fiscal 2020, its last full year as a public company.

When did Itamar Medical go public?

Itamar Medical Ltd stock began trading on March 7, 2019.

Medical Devices stocks to research

All Healthcare stocks →